# Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

> **NCT06789601** · PHASE1,PHASE2 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Malignancy
- Immune Related Adverse Events

## Interventions

- **OTHER:** Informatics system for eligibility monitoring
- **OTHER:** Standard eligibility monitoring

## Key facts

- **NCT ID:** NCT06789601
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-17
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06789601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06789601, "Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06789601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*